Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7671916rdf:typepubmed:Citationlld:pubmed
pubmed-article:7671916lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:7671916lifeskim:mentionsumls-concept:C0239307lld:lifeskim
pubmed-article:7671916lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:7671916lifeskim:mentionsumls-concept:C0376298lld:lifeskim
pubmed-article:7671916lifeskim:mentionsumls-concept:C1541923lld:lifeskim
pubmed-article:7671916lifeskim:mentionsumls-concept:C0282638lld:lifeskim
pubmed-article:7671916lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:7671916lifeskim:mentionsumls-concept:C1512888lld:lifeskim
pubmed-article:7671916pubmed:dateCreated1995-10-13lld:pubmed
pubmed-article:7671916pubmed:abstractTextAntibiotic prophylaxis for infective endocarditis is recommended for cardiac patients at risk who undergo an at-risk procedure. Efforts should focus on patients with the highest risk, i.e., those with a prosthetic valve undergoing a dental procedure. Amoxicillin is the main recommendation in patients who are not allergic to penicillin. In patients allergic to penicillin clindamycin orally or vancomycin intravenously are proposed. Aminoglycosides are added for gastrointestinal or urological procedures.lld:pubmed
pubmed-article:7671916pubmed:languageenglld:pubmed
pubmed-article:7671916pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7671916pubmed:citationSubsetIMlld:pubmed
pubmed-article:7671916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7671916pubmed:statusMEDLINElld:pubmed
pubmed-article:7671916pubmed:monthAprlld:pubmed
pubmed-article:7671916pubmed:issn0195-668Xlld:pubmed
pubmed-article:7671916pubmed:authorpubmed-author:BurckhardtDDlld:pubmed
pubmed-article:7671916pubmed:authorpubmed-author:LeporeRRlld:pubmed
pubmed-article:7671916pubmed:authorpubmed-author:HorstkotteDDlld:pubmed
pubmed-article:7671916pubmed:issnTypePrintlld:pubmed
pubmed-article:7671916pubmed:volume16 Suppl Blld:pubmed
pubmed-article:7671916pubmed:ownerNLMlld:pubmed
pubmed-article:7671916pubmed:authorsCompleteYlld:pubmed
pubmed-article:7671916pubmed:pagination126-31lld:pubmed
pubmed-article:7671916pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:7671916pubmed:meshHeadingpubmed-meshheading:7671916-...lld:pubmed
pubmed-article:7671916pubmed:meshHeadingpubmed-meshheading:7671916-...lld:pubmed
pubmed-article:7671916pubmed:meshHeadingpubmed-meshheading:7671916-...lld:pubmed
pubmed-article:7671916pubmed:meshHeadingpubmed-meshheading:7671916-...lld:pubmed
pubmed-article:7671916pubmed:meshHeadingpubmed-meshheading:7671916-...lld:pubmed
pubmed-article:7671916pubmed:meshHeadingpubmed-meshheading:7671916-...lld:pubmed
pubmed-article:7671916pubmed:year1995lld:pubmed
pubmed-article:7671916pubmed:articleTitleAntibiotic prophylaxis for infective endocarditis from an international group of experts towards a European consensus. Group of Experts of the International Society for Chemotherapy.lld:pubmed
pubmed-article:7671916pubmed:affiliationClaude Bernard Hospital, Paris 7 University, France.lld:pubmed
pubmed-article:7671916pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7671916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7671916lld:pubmed